Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Germany / NCT03091452
Recruiting Observational

CArdioSurgEry Atrial Fibrillation Register

NCT03091452 · tracked via the Priya Life Science Germany tracker
Sponsor
Stiftung Institut fuer Herzinfarktforschung
Phase
Observational
Started
2017-01
Last updated
2025-12-24

Condition(s) studied

Atrial Fibrillation

Study summary

CASE AF aims to describe the reality of medical care of patients in whom atrial fibrillation is treated by cardiac surgical ablation.

Eligibility

Sex
ALL
Min age
18 Years
Max age
100 Years
Healthy volunteers
No
Inclusion Criteria: * Atrial fibrilation * Treated by cardiac surgical ablation Exclusion Criteria: * Patient denies participation

Primary outcome measure(s)

Trial sites (3)

FacilityCityRegionStatus
Klinikum Bogenhausen München Bavaria Recruiting
Asklepios Harburg Hamburg Free and Hanseatic City of Hamburg Not Yet Recruiting
Schüchtermann Kliniken Bad Rothenfelde North Rhine-Westphalia Recruiting

Other trials for the same condition

Non-invasive Differentiation of Supraventricular Tachyarrhythmia Recruiting
Clinical Cohort Study - TRUST Recruiting
Early Treatment of Atrial Fibrillation for Stroke Prevention Trial in Acute STROKE Recruiting
VOLT CE Mark Study Active, not recruiting
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03091452 on ClinicalTrials.gov ↗ ← All trials in Germany